|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 485.16 USD | -2.28% |
|
-8.40% | +7.00% |
| 07-09 | RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $577 From $570 | MT |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- VRTX Stock
- Consensus Vertex Pharmaceuticals Incorporated
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
